Text
New IPA Europe analysis puts hard numbers on how evidence-based probiotic use could cut healthcare costs and boost productivity across the EU.
The authors propose a coordinated framework involving policymakers, scientists, educators, and communities to embed microbiota science into One Health strategies.
Targeting gut bacteria or butyrate could be a promising therapy for glioma.
Dietary fiber during early life protects fertility by supporting healthy gut microbes and preventing ovarian damage caused by high-fat diets.
Gut microbes could be a target for preventing kidney disease-related heart failure.
2 December event in Brussels will unveil new socio-economic analysis on how clearer EU rules for probiotics could cut healthcare costs, drive innovation and strengthen the single market.
Pediatrics, Industry
Sponsored by
Bifidobacterium breve 2TA, Lacticaseibacillus rhamnosus L13B, and Lactobacillus gasseri L6 are not just bacteria: they are witnesses to the intimate, ancestral dialogue between mothers, infants, and microbes.
Restoring beneficial bacteria could lead to new treatments for chronic pain in people with sickle cell disease.
Gut microbes can interact with genetics and hormone metabolism to influence pregnancy outcomes.
Combining data about gut-brain–related disorders with genetic and other information provides a powerful approach for predicting Alzheimer’s and Parkinson’s disease.
